{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:51:31Z","timestamp":1794642691544,"version":"4.9.1"},"reference-count":42,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2006,1,24]],"date-time":"2006-01-24T00:00:00Z","timestamp":1138060800000},"content-version":"vor","delay-in-days":54,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Pharma Physio"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>1.\u2002<jats:italic>trans<\/jats:italic>\u2010Resveratrol (resveratrol) has been shown to have beneficial effects on the cardiovascular system in a number of studies. It is, however, unclear whether this naturally occurring compound can protect against cardiac hypertrophy. The aim of the present study was to investigate the effects of resveratrol on cardiac hypertrophy <jats:italic>in vivo<\/jats:italic> and the potential underlying mechanisms involving endothelin (ET), angiotensin (Ang) II and nitric oxide (NO) in partially nephrectomized rats.<\/jats:p><jats:p>2.\u2002Animal models bearing cardiac hypertrophy were replicated in male Sprague\u2010Dawley rats following partial nephrectomy (PNX). Resveratrol (10 or 50\u00a0mg\/kg) was administered to rats by gavage for 4 weeks. Simultaneous PNX and sham operation controls were simultaneously established in the present study. The systolic blood pressure (SBP) of rats was measured at baseline and, along with heart weight, after 4 weeks treatment. Serum ET\u20101, AngII and NO concentrations were determined.<\/jats:p><jats:p>3.\u2002In the present study, it was shown that, compared with rats in the sham\u2010operated group, rats in the PNX group had significantly higher SBP (154.1\u00a0\u00b1\u00a022.7\u00a0mmHg), heart weight (1.69\u00a0\u00b1\u00a00.24\u00a0g) and serum ET\u20101 (125.70\u00a0\u00b1\u00a026.27\u00a0pg\/mL) and AngII serum concentrations (743.63\u00a0\u00b1\u00a086.50\u00a0pg\/mL), whereas serum NO concentrations were lower (21.1\u00a0\u00b1\u00a06.9\u00a0\u03bcmol\/L; all <jats:italic>P<\/jats:italic>\u00a0&lt; 0.05). These values in the sham control group were 114\u00a0\u00b1\u00a010\u00a0mmHg, 1.28\u00a0\u00b1\u00a00.13\u00a0g, 52.44\u00a0\u00b1\u00a021.85\u00a0pg\/mL, 528.7\u00a0\u00b1\u00a0158.5\u00a0pg\/mL and 53.21\u00a0\u00b1\u00a023.87\u00a0\u00b5mol\/L, respectively. After 4 weeks treatment with 50\u00a0mg\/kg resveratrol, SBP, heart weight and ET\u20101 and AngII concentrations had decreased to 135.4\u00a0\u00b1\u00a015.8\u00a0mmHg, 1.39\u00a0\u00b1\u00a00.15\u00a0g, 97.11\u00a0\u00b1\u00a026.74\u00a0pg\/mL and 629.64\u00a0\u00b1\u00a0116.18\u00a0pg\/mL, respectively. However, the serum NO concentration had increased to 40.1\u00a0\u00b1\u00a014.6\u00a0\u03bcmol\/L. These values were significantly different from those obtained for the PNX group.<\/jats:p><jats:p>4.\u2002In conclusion, <jats:italic>trans<\/jats:italic>\u2010resveratrol appears to be able to protect against the increase in SBP and subsequent cardiac hypertrophy <jats:italic>in vivo<\/jats:italic> and the mechanisms responsible may involve, at least in part, modulation of NO, AngII and ET\u20101 production.<\/jats:p>","DOI":"10.1111\/j.1440-1681.2005.04299.x","type":"journal-article","created":{"date-parts":[[2006,1,24]],"date-time":"2006-01-24T13:30:08Z","timestamp":1138109408000},"page":"1049-1054","source":"Crossref","is-referenced-by-count":45,"title":["Effects of <i>trans<\/i>\u2010resveratrol on hypertension\u2010induced cardiac hypertrophy using the partially nephrectomized rat model"],"prefix":"10.1111","volume":"32","author":[{"given":"Zhaoping","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenming","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changxing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,1,24]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4914(03)00114-X"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1681.2003.03873.x"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1357-2725(02)00344-8"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.41.1.851"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2003.08.008"},{"key":"e_1_2_5_7_2","first-page":"F7","article-title":"Cardiac renin\u2013angiotensin system: Role in development of pressure\u2010overload hypertrophy","volume":"11","author":"Lorell BH","year":"1995","journal-title":"Can. J. Cardiol."},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/bies.20049"},{"key":"e_1_2_5_9_2","first-page":"143","article-title":"Recent advances in the left ventricular hypertrophy","volume":"22","author":"Liang QS","year":"2001","journal-title":"J. Adv. Cardiol."},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1021\/jf0112973"},{"key":"e_1_2_5_11_2","first-page":"58","article-title":"Studies on the antifungal substance of crude drug (II). On the roots of Polygonum cuspidatum Sieb. et Zucc. (Polygonaceae)","volume":"35","author":"Kubo M","year":"1981","journal-title":"Shoyakugaku Zasshi"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.15288\/jsa.2001.62.730"},{"key":"e_1_2_5_13_2","first-page":"317","article-title":"Effect of red wine and wine polyphenol resveratrol on endothelial function in hypercholesterolemic rabbits","volume":"11","author":"Zou JG","year":"2003","journal-title":"Int. J. Mol. Med."},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(99)00410-5"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.3177\/jnsv.46.78"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-3623(95)02001-2"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.62.4.772"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-003-0849-6"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1081\/JDI-100100897"},{"key":"e_1_2_5_20_2","volume-title":"Experimental Methodology in Pharmacology: Advanced Techniques and New Methods.","author":"Liu J","year":"2003"},{"key":"e_1_2_5_21_2","first-page":"394","article-title":"Biological effects of angiotensin II and effects of traditional Chinese medicines on it","volume":"28","author":"Shen Y","year":"2003","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"e_1_2_5_22_2","first-page":"347","article-title":"An overview on endothelin and its effects on cardiovascular diseases","volume":"18","author":"Ni Y","year":"1997","journal-title":"Adv. Cardiovasc. Dis."},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115849"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2004.04.008"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(97)00845-X"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.83.6.1849"},{"key":"e_1_2_5_27_2","first-page":"10","article-title":"Endocrine factors activation of rat myocardium during pressure overload\u2010induced cardiac nypertrophy","volume":"8","author":"Zhou X","year":"2004","journal-title":"J. Chin. Microcirc."},{"key":"e_1_2_5_28_2","first-page":"81","article-title":"Isolation of resveratrol and its antagonistic effects on endothelin\u20101","volume":"15","author":"Yang L","year":"2000","journal-title":"J. West. Chin. Pharmacol."},{"key":"e_1_2_5_29_2","first-page":"272","article-title":"Recent review on beneficial effects of resveratrol on cardiovascular system","volume":"34","author":"Chen L","year":"2003","journal-title":"Shen Li Ke Xue Jin Zhan"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2003.11.026"},{"key":"e_1_2_5_31_2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.33549\/physiolres.930324","article-title":"Role of endothelin and nitric oxide in the pathogenesis of arterial hypertension in autosomal dominant polycystic kidney disease","volume":"52","author":"Merta M","year":"2003","journal-title":"Physiol. Res."},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1681.2003.03930.x"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1681.2002.03619.x"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000103162.76220.51"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1380619"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1021\/jf049295g"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000133734.32125.c7"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(00)00076-6"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2613.2003.00351.x"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(99)00541-4"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200401000-00020"},{"key":"e_1_2_5_42_2","first-page":"213","article-title":"Molecular mechanisms of nitric oxide in preventing cardiomyocytes from hypertrophic response induced by angiotensin II","volume":"54","author":"Liu P","year":"2002","journal-title":"Sheng Li Xue Bao"},{"key":"e_1_2_5_43_2","first-page":"35","article-title":"Effects of nitric oxide on endothelin stimulating hypertrophy and expression of myosin heavy chain genes in cultured rat cardiomyocytes","volume":"16","author":"Yuan C","year":"2000","journal-title":"J. Clin. Cardiol."}],"container-title":["Clinical and Experimental Pharmacology and Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1681.2005.04299.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1681.2005.04299.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1681.2005.04299.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/j.1440-1681.2005.04299.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1681.2005.04299.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T10:49:31Z","timestamp":1694256571000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1681.2005.04299.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["10.1111\/j.1440-1681.2005.04299.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1681.2005.04299.x","archive":["Portico"],"relation":{},"ISSN":["0305-1870","1440-1681"],"issn-type":[{"value":"0305-1870","type":"print"},{"value":"1440-1681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}